WINT

WINDTREE THERAPEUTICS INC /DE/CIK 946486 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for WINT PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for WINT

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Fraser Craig	President and CEO	61	$95.8K	$0	2024-10-08
Simonson Steven	SVP, Chief Medical Officer	32	$13.6K	$0	2024-07-22
Williams Leslie J.	Director	5	$0	$0	2023-08-23
Curtis Eric	SVP & COO	9	$4.6K	$0	2023-08-23
Strobeck Mark	Director	2	$0	$0	2023-08-23
Geffken Daniel E.	Director	9	$15.0K	$0	2023-08-23
SCOTT ROBERT A	Director	5	$0	$0	2023-08-23
CARMAN DIANE	SVP & General Counsel	4	$0	$0	2023-02-28
Huang James	Director, 10% Owner	31	$7.73M	$0	2023-02-22
Hamill John P.	SVP & CFO	9	$13.3K	$0	2022-07-26
Center Laboratories, Inc.	10% Owner	6	$2.38M	$0	2021-12-30
Bioengine Capital Inc.	10% Owner	6	$400.0K	$1.98M	2021-12-30
Schreiber Brian D	Director	4	$15.0K	$0	2021-02-03
Loh Evan	Director	1	$0	$0	2021-02-03
Leone John R	Director	12	$15.0K	$0	2021-02-03
PEACOCK BRUCE	Director	12	$25.4K	$0	2021-02-03
Joseph Mahady M	Director	12	$15.0K	$0	2021-02-03
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	8	$8.0K	$0	2020-05-22
Tattory John A	SVP & CFO	16	$3.3K	$0	2020-05-22
LPH II Investments Ltd	10% Owner	5	$10.99M	$0	2019-12-06
Lee's Pharmaceutical Holdings Ltd	10% Owner	10	$47.06M	$0	2019-12-06
ROSENTHALE MARVIN E	Director	2	$0	$0	2016-08-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Fraser Craig	President and CEO	P Buy	2024-10-08	2024-10-09	5,431	$0.91	$4.9K	8,638	SEC↗
Fraser Craig	President and CEO	A Award deriv	2024-07-22	2024-07-24	4,011	—	$0	4,011	SEC↗
Fraser Craig	President and CEO	A Award deriv	2024-07-22	2024-07-24	19	—	$0	19	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2024-07-22	2024-07-24	13	—	$0	13	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2024-07-22	2024-07-24	2,674	—	$0	2,674	SEC↗
Fraser Craig	President and CEO	P Buy	2023-09-27	2023-09-28	2,500	$1.02	$2.5K	57,877	SEC↗
Fraser Craig	President and CEO	P Buy	2023-09-26	2023-09-27	2,500	$0.90	$2.3K	55,377	SEC↗
Fraser Craig	President and CEO	A Award deriv	2023-08-23	2023-08-25	68,800	—	$0	68,800	SEC↗
Curtis Eric	SVP & COO	A Award deriv	2023-08-23	2023-08-25	22,000	—	$0	22,000	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2023-08-23	2023-08-25	23,800	—	$0	23,800	SEC↗
SCOTT ROBERT A	Director	A Award deriv	2023-08-23	2023-08-25	3,050	—	$0	3,050	SEC↗
Strobeck Mark	Director	A Award deriv	2023-08-23	2023-08-25	3,450	—	$0	3,450	SEC↗
Williams Leslie J.	Director	A Award deriv	2023-08-23	2023-08-25	3,050	—	$0	3,050	SEC↗
Geffken Daniel E.	Director	A Award deriv	2023-08-23	2023-08-29	3,050	—	$0	3,050	SEC↗
Fraser Craig	President and CEO	A Award	2023-08-23	2023-08-25	45,867	—	$0	52,877	SEC↗
Curtis Eric	SVP & COO	A Award	2023-08-23	2023-08-25	14,667	—	$0	15,920	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award	2023-08-23	2023-08-25	15,867	—	$0	17,440	SEC↗
SCOTT ROBERT A	Director	A Award	2023-08-23	2023-08-25	2,033	—	$0	2,133	SEC↗
Strobeck Mark	Director	A Award	2023-08-23	2023-08-25	2,300	—	$0	2,300	SEC↗
Williams Leslie J.	Director	A Award	2023-08-23	2023-08-25	2,033	—	$0	2,133	SEC↗
Geffken Daniel E.	Director	A Award	2023-08-23	2023-08-29	2,033	—	$0	2,175	SEC↗
Fraser Craig	President and CEO	P Buy	2023-04-26	2023-04-27	1,497	$1.77	$2.6K	7,010	SEC↗
Fraser Craig	President and CEO	P Buy	2023-04-25	2023-04-26	1,315	$1.89	$2.5K	5,513	SEC↗
CARMAN DIANE	SVP & General Counsel	F Tax w/h	2023-02-28	2023-03-02	99	—	$0	1,227	SEC↗
Curtis Eric	SVP & COO	F Tax w/h	2023-02-28	2023-03-02	99	—	$0	1,253	SEC↗
Fraser Craig	President and CEO	F Tax w/h	2023-02-28	2023-03-02	334	—	$0	4,198	SEC↗
Simonson Steven	SVP, Chief Medical Officer	F Tax w/h	2023-02-28	2023-03-02	100	—	$0	1,573	SEC↗
Huang James	Director	X Exercise deriv	2023-02-22	2023-02-23	1,112,308	—	$0	0	SEC↗
Huang James	Director	A Award deriv	2023-02-22	2023-02-23	1,112,308	—	$0	1,112,308	SEC↗
Huang James	Director	D To issuer deriv	2023-02-22	2023-02-23	62,500	—	$0	0	SEC↗
Huang James	Director	A Award deriv	2023-02-22	2023-02-23	2,224,616	—	$0	2,224,616	SEC↗
Huang James	Director	D To issuer deriv	2023-02-22	2023-02-23	498,008	—	$0	0	SEC↗
Huang James	Director	D To issuer deriv	2023-02-22	2023-02-23	275,862	—	$0	0	SEC↗
Huang James	Director	D To issuer deriv	2023-02-22	2023-02-23	275,938	—	$0	0	SEC↗
Huang James	Director	X Exercise	2023-02-22	2023-02-23	1,112,308	$0.14	$155.7K	3,449,161	SEC↗
Fraser Craig	President and CEO	P Buy	2022-07-27	2022-07-27	2,500	$0.38	$950	226,558	SEC↗
Fraser Craig	President and CEO	P Buy	2022-07-26	2022-07-26	2,500	$0.37	$925	224,058	SEC↗
Hamill John P.	SVP & CFO	P Buy	2022-07-26	2022-07-26	3,000	$0.37	$1.1K	72,800	SEC↗
Fraser Craig	President and CEO	P Buy	2022-06-30	2022-07-05	4,500	$0.43	$1.9K	221,558	SEC↗
Fraser Craig	President and CEO	P Buy	2022-06-29	2022-06-30	7,000	$0.42	$2.9K	217,058	SEC↗
Geffken Daniel E.	Director	A Award deriv	2022-06-07	2022-06-09	7,500	—	$0	7,500	SEC↗
Huang James	Director	A Award deriv	2022-06-07	2022-06-09	7,500	—	$0	7,500	SEC↗
SCOTT ROBERT A	Director	A Award deriv	2022-06-07	2022-06-09	7,500	—	$0	7,500	SEC↗
Williams Leslie J.	Director	A Award deriv	2022-06-07	2022-06-09	7,500	—	$0	7,500	SEC↗
Geffken Daniel E.	Director	A Award	2022-06-07	2022-06-09	5,000	—	$0	7,069	SEC↗
Huang James	Director	A Award	2022-06-07	2022-06-09	5,000	—	$0	296,281	SEC↗
SCOTT ROBERT A	Director	A Award	2022-06-07	2022-06-09	5,000	—	$0	5,000	SEC↗
Williams Leslie J.	Director	A Award	2022-06-07	2022-06-09	5,000	—	$0	5,000	SEC↗
Fraser Craig	President and CEO	P Buy	2022-03-16	2022-03-17	2,000	$0.98	$2.0K	210,058	SEC↗
Fraser Craig	President and CEO	P Buy	2022-03-15	2022-03-15	3,000	$0.98	$2.9K	208,058	SEC↗
Simonson Steven	SVP, Chief Medical Officer	P Buy	2022-03-15	2022-03-15	5,000	$1.00	$5.0K	83,602	SEC↗
CARMAN DIANE	SVP & General Counsel	A Award deriv	2022-03-04	2022-03-07	99,600	—	$0	99,600	SEC↗
Curtis Eric	SVP & COO	A Award deriv	2022-03-04	2022-03-07	99,600	—	$0	99,600	SEC↗
Fraser Craig	President and CEO	A Award deriv	2022-03-04	2022-03-07	250,400	—	$0	250,400	SEC↗
Hamill John P.	SVP & CFO	A Award deriv	2022-03-04	2022-03-07	99,600	—	$0	99,600	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2022-03-04	2022-03-07	99,600	—	$0	99,600	SEC↗
CARMAN DIANE	SVP & General Counsel	A Award	2022-03-04	2022-03-07	66,300	—	$0	66,300	SEC↗
Curtis Eric	SVP & COO	A Award	2022-03-04	2022-03-07	66,300	—	$0	67,591	SEC↗
Fraser Craig	President and CEO	A Award	2022-03-04	2022-03-07	166,900	—	$0	205,058	SEC↗
Hamill John P.	SVP & CFO	A Award	2022-03-04	2022-03-07	66,300	—	$0	69,800	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award	2022-03-04	2022-03-07	66,300	—	$0	78,602	SEC↗
Bioengine Capital Inc.	10% Owner	S Sale	2021-12-30	2022-01-10	1,239,088	$1.60	$1.98M	0	SEC↗
Center Laboratories, Inc.	10% Owner	P Buy	2021-12-30	2022-01-10	1,239,088	$1.60	$1.98M	1,239,088	SEC↗
Fraser Craig	President and CEO	P Buy	2021-11-19	2021-11-22	930	$1.60	$1.5K	38,158	SEC↗
Fraser Craig	President and CEO	P Buy	2021-11-18	2021-11-18	930	$1.61	$1.5K	37,228	SEC↗
Fraser Craig	President and CEO	P Buy	2021-10-22	2021-10-25	3,000	$1.90	$5.7K	36,298	SEC↗
Fraser Craig	President and CEO	P Buy	2021-10-19	2021-10-19	3,000	$1.91	$5.7K	33,298	SEC↗
Huang James	Director	P Buy	2021-10-19	2021-10-19	50,000	$1.90	$95.0K	291,281	SEC↗
CARMAN DIANE	SVP & General Counsel	A Award deriv	2021-07-01	2021-07-06	150,000	—	$0	150,000	SEC↗
Geffken Daniel E.	Director	A Award deriv	2021-06-15	2021-06-17	15,000	—	$0	15,000	SEC↗
Huang James	Director	A Award deriv	2021-06-15	2021-06-17	15,000	—	$0	15,000	SEC↗
Hamill John P.	SVP & CFO	P Buy	2021-04-16	2021-04-19	1,000	$2.07	$2.1K	3,500	SEC↗
Fraser Craig	President and CEO	P Buy	2021-04-16	2021-04-20	1,000	$2.09	$2.1K	30,298	SEC↗
Fraser Craig	President and CEO	P Buy	2021-04-15	2021-04-19	1,000	$2.24	$2.2K	29,298	SEC↗
Curtis Eric	SVP & COO	P Buy	2021-04-07	2021-04-08	791	$2.52	$2.0K	1,291	SEC↗
Fraser Craig	President and CEO	P Buy	2021-04-06	2021-04-07	500	$2.57	$1.3K	28,298	SEC↗
Fraser Craig	President and CEO	P Buy	2021-04-05	2021-04-06	1,000	$2.58	$2.6K	27,798	SEC↗
Fraser Craig	President and CEO	P Buy	2021-04-01	2021-04-05	500	$2.46	$1.2K	26,798	SEC↗
Huang James	Director, 10% Owner	P Buy	2021-03-31	2021-04-02	150,000	$2.36	$354.0K	171,000	SEC↗
Fraser Craig	President and CEO	P Buy	2021-03-31	2021-03-31	500	$2.32	$1.2K	26,298	SEC↗
Fraser Craig	President and CEO	P Buy deriv	2021-03-25	2021-03-25	1,500	—	$0	1,500	SEC↗
Hamill John P.	SVP & CFO	P Buy deriv	2021-03-25	2021-03-25	1,500	—	$0	1,500	SEC↗
Simonson Steven	SVP, Chief Medical Officer	P Buy deriv	2021-03-25	2021-03-25	1,500	—	$0	1,500	SEC↗
Fraser Craig	President and CEO	P Buy	2021-03-25	2021-03-25	1,500	$3.25	$4.9K	25,798	SEC↗
Hamill John P.	SVP & CFO	P Buy	2021-03-25	2021-03-25	1,500	$3.25	$4.9K	2,500	SEC↗
Simonson Steven	SVP, Chief Medical Officer	P Buy	2021-03-25	2021-03-25	1,500	$3.25	$4.9K	12,302	SEC↗
Loh Evan	Director	A Award deriv	2021-02-03	2021-02-05	30,000	—	$0	30,000	SEC↗
Williams Leslie J.	Director	A Award deriv	2021-02-03	2021-02-05	30,000	—	$0	30,000	SEC↗
Leone John R	Director	A Award deriv	2021-02-03	2021-02-05	15,000	—	$0	15,000	SEC↗
Joseph Mahady M	Director	A Award deriv	2021-02-03	2021-02-05	15,000	—	$0	15,000	SEC↗
Schreiber Brian D	Director	A Award deriv	2021-02-03	2021-02-05	15,000	—	$0	15,000	SEC↗
Geffken Daniel E.	Director	A Award deriv	2021-02-03	2021-02-05	15,000	—	$0	15,000	SEC↗
Huang James	Director, 10% Owner	A Award deriv	2021-02-03	2021-02-05	15,000	—	$0	15,000	SEC↗
PEACOCK BRUCE	Director	A Award deriv	2021-02-03	2021-02-05	15,000	—	$0	15,000	SEC↗
SCOTT ROBERT A	Director	A Award deriv	2021-02-03	2021-02-09	30,000	—	$0	30,000	SEC↗
Curtis Eric	SVP & COO	A Award deriv	2021-01-22	2021-01-26	60,000	—	$0	60,000	SEC↗
Fraser Craig	President and CEO	A Award deriv	2021-01-22	2021-01-26	143,250	—	$0	143,250	SEC↗
Fraser Craig	President and CEO	A Award deriv	2021-01-22	2021-01-26	143,250	—	$0	143,250	SEC↗
Hamill John P.	SVP & CFO	A Award deriv	2021-01-22	2021-01-26	60,000	—	$0	60,000	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2021-01-22	2021-01-26	52,600	—	$0	52,600	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2021-01-22	2021-01-26	60,000	—	$0	60,000	SEC↗
Fraser Craig	President and CEO	P Buy	2020-10-28	2020-10-29	250	$6.56	$1.6K	24,298	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-10-23	2020-10-27	1,000	$6.67	$6.7K	21,000	SEC↗
Fraser Craig	President and CEO	P Buy	2020-10-09	2020-10-13	250	$5.83	$1.5K	24,048	SEC↗
Curtis Eric	SVP & COO	P Buy	2020-10-08	2020-10-09	500	$5.27	$2.6K	500	SEC↗
Fraser Craig	President and CEO	P Buy	2020-10-07	2020-10-09	250	$5.17	$1.3K	23,798	SEC↗
Hamill John P.	SVP & CFO	P Buy	2020-10-07	2020-10-09	1,000	$5.27	$5.3K	1,000	SEC↗
Curtis Eric	SVP & COO	A Award deriv	2020-07-29	2020-10-09	205,461	—	$0	205,461	SEC↗
Hamill John P.	SVP & CFO	A Award deriv	2020-07-20	2020-07-22	211,000	—	$0	211,000	SEC↗
Bioengine Capital Inc.	10% Owner	J Other deriv	2020-06-24	2022-01-10	0	—	$0	0	SEC↗
Center Laboratories, Inc.	10% Owner	J Other deriv	2020-06-24	2022-01-10	0	—	$0	0	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-06-04	2020-10-26	12,000	$7.32	$87.8K	20,000	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-06-04	2020-06-05	12,200	$7.32	$89.3K	20,200	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-06-03	2020-06-05	200	$7.42	$1.5K	8,000	SEC↗
Geffken Daniel E.	Director	P Buy deriv	2020-05-22	2020-05-27	2,069	—	$0	2,069	SEC↗
Huang James	Director, 10% Owner	P Buy deriv	2020-05-22	2020-05-27	275,862	—	$0	275,862	SEC↗
Leone John R	Director	P Buy deriv	2020-05-22	2020-05-27	2,069	—	$0	2,069	SEC↗
Joseph Mahady M	Director	P Buy deriv	2020-05-22	2020-05-27	2,069	—	$0	2,069	SEC↗
PEACOCK BRUCE	Director	P Buy deriv	2020-05-22	2020-05-27	3,500	—	$0	3,500	SEC↗
Schreiber Brian D	Director	P Buy deriv	2020-05-22	2020-05-27	2,069	—	$0	2,069	SEC↗
Fraser Craig	President and CEO	P Buy deriv	2020-05-22	2020-05-27	2,069	—	$0	2,069	SEC↗
Simonson Steven	SVP, Chief Medical Officer	P Buy deriv	2020-05-22	2020-05-27	517	—	$0	517	SEC↗
Tattory John A	SVP & CFO	P Buy deriv	2020-05-22	2020-05-27	449	—	$0	449	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	P Buy deriv	2020-05-22	2020-05-27	1,103	—	$0	1,103	SEC↗
Geffken Daniel E.	Director	P Buy	2020-05-22	2020-05-27	2,069	$7.25	$15.0K	2,069	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-05-22	2020-05-27	275,862	$7.25	$2.00M	2,336,853	SEC↗
Leone John R	Director	P Buy	2020-05-22	2020-05-27	2,069	$7.25	$15.0K	7,473	SEC↗
Joseph Mahady M	Director	P Buy	2020-05-22	2020-05-27	2,069	$7.25	$15.0K	7,455	SEC↗
PEACOCK BRUCE	Director	P Buy	2020-05-22	2020-05-27	3,500	$7.25	$25.4K	8,886	SEC↗
Schreiber Brian D	Director	P Buy	2020-05-22	2020-05-27	2,069	$7.25	$15.0K	2,069	SEC↗
Fraser Craig	President and CEO	P Buy	2020-05-22	2020-05-27	2,069	$7.25	$15.0K	23,548	SEC↗
Simonson Steven	SVP, Chief Medical Officer	P Buy	2020-05-22	2020-05-27	517	$7.25	$3.7K	10,802	SEC↗
Tattory John A	SVP & CFO	P Buy	2020-05-22	2020-05-27	449	$7.25	$3.3K	9,280	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	P Buy	2020-05-22	2020-05-27	1,103	$7.25	$8.0K	1,134	SEC↗
Bioengine Capital Inc.	10% Owner	J Other deriv	2020-05-20	2022-01-10	249,004	—	$0	249,004	SEC↗
Bioengine Capital Inc.	10% Owner	P Buy deriv	2020-05-20	2022-01-10	55,172	—	$0	55,172	SEC↗
Center Laboratories, Inc.	10% Owner	P Buy deriv	2020-05-20	2022-01-10	55,172	—	$0	55,172	SEC↗
Center Laboratories, Inc.	10% Owner	J Other deriv	2020-05-20	2022-01-10	249,004	—	$0	249,004	SEC↗
Bioengine Capital Inc.	10% Owner	P Buy	2020-05-20	2022-01-10	55,172	$7.25	$400.0K	1,239,088	SEC↗
Bioengine Capital Inc.	10% Owner	J Other	2020-05-20	2022-01-10	3,551,750	—	$0	1,183,916	SEC↗
Center Laboratories, Inc.	10% Owner	J Other	2020-05-20	2022-01-10	3,551,750	—	$0	1,183,916	SEC↗
Center Laboratories, Inc.	10% Owner	P Buy	2020-05-20	2022-01-10	55,172	$7.25	$400.0K	1,239,088	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-02-18	2020-02-20	400	$3.84	$1.5K	23,400	SEC↗
Fraser Craig	President and CEO	P Buy	2020-02-11	2020-02-12	250	$4.10	$1.0K	63,590	SEC↗
Fraser Craig	President and CEO	P Buy	2020-02-10	2020-02-12	250	$4.10	$1.0K	63,340	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-02-07	2020-02-07	500	$4.05	$2.0K	23,000	SEC↗
Fraser Craig	President and CEO	P Buy	2020-02-04	2020-02-05	500	$4.24	$2.1K	63,090	SEC↗
Fraser Craig	President and CEO	P Buy	2020-02-03	2020-02-05	100	$4.20	$420	62,590	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-01-17	2020-01-21	2,000	$4.18	$8.4K	22,500	SEC↗
Huang James	Director, 10% Owner	P Buy	2020-01-16	2020-01-21	58	$4.20	$244	20,500	SEC↗
Huang James	Director, 10% Owner	P Buy	2019-12-31	2020-01-03	15,442	$4.05	$62.5K	20,442	SEC↗
Huang James	Director, 10% Owner	P Buy	2019-12-30	2019-12-31	909	$3.81	$3.5K	5,000	SEC↗
Huang James	Director, 10% Owner	P Buy	2019-12-27	2019-12-31	4,091	$3.73	$15.3K	4,091	SEC↗
Huang James	Director, 10% Owner	P Buy deriv	2019-12-06	2019-12-10	827,815	—	$0	827,815	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy deriv	2019-12-06	2019-12-10	827,815	—	$0	827,815	SEC↗
LPH II Investments Ltd	10% Owner	P Buy deriv	2019-12-06	2019-12-10	827,815	—	$0	827,815	SEC↗
Huang James	Director, 10% Owner	A Award	2019-12-06	2019-12-10	96,429	—	$0	210,844	SEC↗
Huang James	Director, 10% Owner	P Buy	2019-12-06	2019-12-10	1,655,629	$3.02	$5.00M	6,182,974	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy	2019-12-06	2019-12-10	1,655,629	$3.02	$5.00M	14,450,599	SEC↗
LPH II Investments Ltd	10% Owner	P Buy	2019-12-06	2019-12-10	1,655,629	$3.02	$5.00M	4,008,234	SEC↗
Leone John R	Director	A Award deriv	2019-06-28	2019-07-02	40,000	—	$0	40,000	SEC↗
Joseph Mahady M	Director	A Award deriv	2019-06-28	2019-07-02	40,000	—	$0	40,000	SEC↗
PEACOCK BRUCE	Director	A Award deriv	2019-06-28	2019-07-02	40,000	—	$0	40,000	SEC↗
Geffken Daniel E.	Director	A Award deriv	2019-04-24	2019-04-26	60,000	—	$0	60,000	SEC↗
Huang James	Director, 10% Owner	A Award deriv	2019-04-24	2019-04-26	60,000	—	$0	60,000	SEC↗
Schreiber Brian D	Director	A Award deriv	2019-04-24	2019-04-26	60,000	—	$0	60,000	SEC↗
Fraser Craig	President and CEO	A Award deriv	2019-03-19	2019-03-21	100,000	—	$0	100,000	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2019-03-19	2019-03-21	50,000	—	$0	50,000	SEC↗
Tattory John A	SVP & CFO	A Award deriv	2019-03-19	2019-03-21	50,000	—	$0	50,000	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	A Award deriv	2019-03-19	2019-03-21	40,000	—	$0	40,000	SEC↗
Fraser Craig	President and CEO	F Tax w/h	2019-03-15	2020-05-27	18,023	—	$0	63,337	SEC↗
Simonson Steven	SVP, Chief Medical Officer	F Tax w/h	2019-03-15	2020-05-27	8,979	—	$0	30,856	SEC↗
Tattory John A	SVP & CFO	F Tax w/h	2019-03-15	2020-05-27	9,708	—	$0	26,495	SEC↗
Fraser Craig	President and CEO	F Tax w/h	2019-03-15	2019-03-19	20,641	—	$0	62,490	SEC↗
Simonson Steven	SVP, Chief Medical Officer	F Tax w/h	2019-03-15	2019-03-19	9,824	—	$0	30,011	SEC↗
Tattory John A	SVP & CFO	F Tax w/h	2019-03-15	2019-03-19	10,281	—	$0	25,922	SEC↗
Fraser Craig	President and CEO	D To issuer	2019-02-07	2020-05-27	83,257	—	$0	725	SEC↗
Fraser Craig	President and CEO	F Tax w/h	2019-02-07	2020-05-27	18,175	—	$0	81,360	SEC↗
Fraser Craig	President and CEO	A Award	2019-02-07	2020-05-27	98,810	—	$0	99,535	SEC↗
Fraser Craig	President and CEO	D To issuer	2019-02-07	2019-02-11	83,257	—	$0	725	SEC↗
Fraser Craig	President and CEO	A Award	2019-02-07	2019-02-11	98,810	—	$0	99,535	SEC↗
Fraser Craig	President and CEO	F Tax w/h	2019-02-07	2019-02-11	16,404	—	$0	83,131	SEC↗
Simonson Steven	SVP, Chief Medical Officer	D To issuer	2019-02-07	2019-02-11	23,514	—	$0	16,321	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award	2019-02-07	2019-02-11	23,514	—	$0	39,835	SEC↗
Tattory John A	SVP & CFO	D To issuer	2019-02-07	2019-02-11	22,078	—	$0	14,125	SEC↗
Tattory John A	SVP & CFO	A Award	2019-02-07	2019-02-11	22,078	—	$0	36,203	SEC↗
Fraser Craig	President and CEO	F Tax w/h	2018-12-28	2019-01-02	15,553	$5.00	$77.8K	83,982	SEC↗
Simonson Steven	SVP, Chief Medical Officer	F Tax w/h	2018-12-28	2019-01-02	7,402	$5.00	$37.0K	39,835	SEC↗
Tattory John A	SVP & CFO	F Tax w/h	2018-12-28	2019-01-02	8,007	$5.00	$40.0K	36,203	SEC↗
Leone John R	Director	A Award deriv	2018-12-24	2018-12-27	32,000	—	$0	32,000	SEC↗
Joseph Mahady M	Director	A Award deriv	2018-12-24	2018-12-27	32,000	—	$0	32,000	SEC↗
PEACOCK BRUCE	Director	A Award deriv	2018-12-24	2018-12-27	32,000	—	$0	32,000	SEC↗
Fraser Craig	President and CEO	A Award deriv	2018-12-24	2018-12-27	1,265,717	—	$0	1,265,717	SEC↗
Simonson Steven	SVP, Chief Medical Officer	A Award deriv	2018-12-24	2018-12-27	738,335	—	$0	738,335	SEC↗
Tattory John A	SVP & CFO	A Award deriv	2018-12-24	2018-12-27	738,335	—	$0	738,335	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	A Award deriv	2018-12-24	2018-12-27	421,906	—	$0	421,906	SEC↗
Leone John R	Director	A Award	2018-12-24	2018-12-27	15,000	—	$0	16,212	SEC↗
Joseph Mahady M	Director	A Award	2018-12-24	2018-12-27	15,000	—	$0	16,160	SEC↗
PEACOCK BRUCE	Director	A Award	2018-12-24	2018-12-27	15,000	—	$0	16,160	SEC↗
LPH II Investments Ltd	10% Owner	P Buy deriv	2018-12-21	2018-12-26	307,859	—	$0	1,040,886	SEC↗
LPH II Investments Ltd	10% Owner	P Buy deriv	2018-12-21	2018-12-26	597,610	—	$0	1,040,886	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy deriv	2018-12-21	2018-12-26	307,859	—	$0	1,042,224	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy deriv	2018-12-21	2018-12-26	597,610	—	$0	1,042,224	SEC↗
LPH II Investments Ltd	10% Owner	P Buy	2018-12-21	2018-12-26	1,810,938	$3.31	$5.99M	2,352,605	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy	2018-12-21	2018-12-26	8,063,861	$4.15	$33.47M	12,794,970	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy	2018-12-21	2018-12-26	1,810,938	$3.31	$5.99M	12,794,970	SEC↗
Leone John R	Director	C Conversion deriv	2018-11-21	2018-11-23	13	—	$0	0	SEC↗
Joseph Mahady M	Director	C Conversion deriv	2018-11-21	2018-11-23	17	—	$0	0	SEC↗
PEACOCK BRUCE	Director	C Conversion deriv	2018-11-21	2018-11-23	17	—	$0	0	SEC↗
Fraser Craig	President and CEO	C Conversion deriv	2018-11-21	2018-11-23	7	—	$0	0	SEC↗
Simonson Steven	SVP, Chief Development Offic	C Conversion deriv	2018-11-21	2018-11-23	3	—	$0	0	SEC↗
Leone John R	Director	C Conversion	2018-11-21	2018-11-23	650	—	$0	1,212	SEC↗
Joseph Mahady M	Director	C Conversion	2018-11-21	2018-11-23	850	—	$0	1,160	SEC↗
PEACOCK BRUCE	Director	C Conversion	2018-11-21	2018-11-23	850	—	$0	1,160	SEC↗
Fraser Craig	President and CEO	C Conversion	2018-11-21	2018-11-23	350	—	$0	99,535	SEC↗
Simonson Steven	SVP, Chief Development Offic	C Conversion	2018-11-21	2018-11-23	150	—	$0	47,237	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	C Conversion deriv	2018-11-08	2018-12-26	1,338	—	$0	136,755	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	C Conversion	2018-11-08	2018-12-26	66,900	—	$0	2,920,171	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy deriv	2018-04-04	2018-04-06	135,417	—	$0	135,417	SEC↗
Lee's Pharmaceutical Holdings	10% Owner	P Buy	2018-04-04	2018-04-06	541,667	$4.80	$2.60M	2,853,271	SEC↗
Fraser Craig	President and CEO	A Award	2017-11-01	2017-11-03	1,976,190	—	$0	1,983,690	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award	2017-11-01	2017-11-03	940,564	—	$0	941,756	SEC↗
Tattory John A	SVP & CFO	A Award	2017-11-01	2017-11-03	883,144	—	$0	884,215	SEC↗
Fraser Craig	President and CEO	A Award deriv	2017-03-01	2017-03-03	100,000	—	$0	100,000	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award deriv	2017-03-01	2017-03-03	36,666	—	$0	36,666	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award deriv	2017-03-01	2017-03-03	18,334	—	$0	18,334	SEC↗
Tattory John A	SVP & CFO	A Award deriv	2017-03-01	2017-03-03	11,239	—	$0	11,239	SEC↗
Tattory John A	SVP & CFO	A Award deriv	2017-03-01	2017-03-03	43,761	—	$0	43,761	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	A Award deriv	2017-03-01	2017-03-03	50,000	—	$0	50,000	SEC↗
Fraser Craig	President and CEO	P Buy deriv	2017-02-13	2017-02-15	7	—	$0	7	SEC↗
Fraser Craig	President and CEO	P Buy deriv	2017-02-13	2017-02-15	7,000	—	$0	7,000	SEC↗
Simonson Steven	SVP, Chief Development Offic	P Buy deriv	2017-02-13	2017-02-15	3,000	—	$0	3,000	SEC↗
Simonson Steven	SVP, Chief Development Offic	P Buy deriv	2017-02-13	2017-02-15	3	—	$0	3	SEC↗
Leone John R	Director	P Buy deriv	2017-02-13	2017-02-15	13,000	—	$0	13,000	SEC↗
Leone John R	Director	P Buy deriv	2017-02-13	2017-02-15	13	—	$0	13	SEC↗
Joseph Mahady M	Director	P Buy deriv	2017-02-13	2017-02-15	17,000	—	$0	17,000	SEC↗
Joseph Mahady M	Director	P Buy deriv	2017-02-13	2017-02-15	17	—	$0	17	SEC↗
PEACOCK BRUCE	Director	P Buy deriv	2017-02-13	2017-02-15	17,000	—	$0	17,000	SEC↗
PEACOCK BRUCE	Director	P Buy deriv	2017-02-13	2017-02-15	17	—	$0	17	SEC↗
Fraser Craig	President and CEO	P Buy	2016-10-28	2016-11-01	7,500	$2.05	$15.4K	7,500	SEC↗
Leone John R	Director	A Award deriv	2016-08-04	2016-08-08	15,000	—	$0	15,000	SEC↗
Joseph Mahady M	Director	A Award deriv	2016-08-04	2016-08-08	15,000	—	$0	15,000	SEC↗
PEACOCK BRUCE	Director	A Award deriv	2016-08-04	2016-08-08	15,000	—	$0	15,000	SEC↗
ROSENTHALE MARVIN E	Director	A Award deriv	2016-08-04	2016-08-08	15,000	—	$0	15,000	SEC↗
Leone John R	Director	A Award	2016-08-04	2016-08-08	4,348	—	$0	11,250	SEC↗
Joseph Mahady M	Director	A Award	2016-08-04	2016-08-08	4,348	—	$0	6,211	SEC↗
PEACOCK BRUCE	Director	A Award	2016-08-04	2016-08-08	4,348	—	$0	6,211	SEC↗
ROSENTHALE MARVIN E	Director	A Award	2016-08-04	2016-08-08	4,348	—	$0	6,211	SEC↗
Fraser Craig	President and CEO	A Award deriv	2016-07-28	2016-08-01	40,000	—	$0	40,000	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award deriv	2016-07-28	2016-08-01	8,333	—	$0	8,333	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award deriv	2016-07-28	2016-08-01	16,667	—	$0	16,667	SEC↗
Tattory John A	SVP & CFO	A Award deriv	2016-07-28	2016-08-01	16,666	—	$0	16,666	SEC↗
Tattory John A	SVP & CFO	A Award deriv	2016-07-28	2016-08-01	8,334	—	$0	8,334	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	A Award deriv	2016-07-28	2016-08-01	10,000	—	$0	10,000	SEC↗
Fraser Craig	President and CEO	A Award	2016-06-30	2016-08-01	1,078	$1.93	$2.1K	1,078	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award	2016-06-30	2016-08-01	1,166	$1.93	$2.3K	6,884	SEC↗
Tattory John A	SVP & CFO	A Award	2016-06-30	2016-08-01	1,088	$1.93	$2.1K	6,555	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	A Award	2016-06-30	2016-08-01	1,166	$1.93	$2.3K	9,270	SEC↗
Simonson Steven	SVP, Chief Development Offic	A Award	2016-03-31	2016-08-01	1,347	$1.67	$2.2K	5,718	SEC↗
Tattory John A	SVP & CFO	A Award	2016-03-31	2016-08-01	1,077	$1.67	$1.8K	5,467	SEC↗
Templeton Mary B Esq	SVP, Gen Counsel & Corp Sec	A Award	2016-03-31	2016-08-01	1,347	$1.67	$2.2K	8,104	SEC↗